About SATB2-associated syndrome

Individuals with SATB2-associated syndrome (2q33.1) are generally very kind and happy, with the most beautiful smiles you may have ever seen.  However, this syndrome significantly affects all areas of development, including speech (absent speech in most or significantly delayed/affected speech), cognition (intellectual disability), fine motor skills, and gross motor skills.  Individuals with SATB2-associated syndrome have palatal abnormalities, including cleft palate and high arched palate, as well as dental issues, including large teeth.  They also suffer from a number of other medical issues, and as the children get older, significant behavioral issues develop.

Our group is fortunate to work closely with Dr. Yuri Zarate, of the Arkansas Children's Hospital.  Dr. Zarate (better known to our group as Dr. Z) is the leading expert in the treatment of individuals with SATB2-associated syndrome (SAS) and SAS-related research.  He has initiated a project to collect clinical information on patients with SAS to increase our knowledge of this condition.  Parents and clinicians are encouraged to contact Dr. Zarate for further information about enrolling in the SATB2-associated syndrome registry.  Currently, over 90 families are enrolled.  

To learn more about the importance and how to enroll in the SAS registry, please click here.

For further medical information, please click here. 

Yuri Zarate, MD, MBA
Associate Professor, Section of Genetics and Metabolism
University of Arkansas for Medical Sciences
Arkansas Children’s Hospital
1 Children’s Way Slot 512-22
Little Rock, AR 72202
Phone   501-364-1926/ FAX: 501-364-1564
email    yazarate@uams.edu

Update as of October 2018: New SATB2 Dental Research published in Clinical Oral Investigations. This paper reviews the dental findings from the first SATB2-associated syndrome clinic that took place in 2017.

Click here to view and download the publication.

Also available for viewing is the presentation made by Dr. John Scott, DDS and Dr. Chad Adams, DDS of Arkansas Children’s Hospital during the 2018 International SATB2-associated syndrome conference held in Little Rock, Arkansas, USA.